Demand for Biopharmaceuticals and Biologics to Boost Cell Culture Media, Sera, and Reagents Market to USD 2.8 Billion by 2020

According to a new market research report published by iHealthcareAnalyst, Inc., Cell Culture Media, Sera, Reagents Market - Global Media, Serum and Reagent Products Analysis and Forecast 2013-2020, the global cell culture media, sera, reagents market is estimated to reach USD 2.8 Billion in 2020, expanding at a CAGR of 11.8% from 2016 to 2020.

Visit the Cell Culture Media, Sera, Reagents Market - Global Media, Serum and Reagent Products Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/cell-culture-media-sera-reagents-market/

There are different media requirement for various cell types. Serum based media are widely used to grow a broad range of animal cell lines. Serum is a complex mix of albumins, growth factors and growth inhibitors which is also a source of amino acids, proteins, vitamins (A, D, E, and K), carbohydrates, lipids, hormones, growth factors, minerals, and trace elements. Cell culture components or reagents provide an ideal growth environment as per the cell types. The cell culture media, sera, reagents market report estimates the market size (Revenue USD million - 2013 to 2020) and composition of this market in terms of culture and media types and forecasts growth trends (CAGR% - 2016 to 2020). It also covers the major competitors operating in the market and provides a bird’s eye view of the major culture media, sera and reagent products in the global market.

The global cell culture media, sera, reagents market is segmented as:

1. Media Type
1.1. Chemically Defined Media
1.2. Classical media
1.3. Lysogeny broth (LB)
1.4. Protein-free media
1.5. Serum-free media
1.6. Specialty media

2. Serum Type
2.1. Fetal Bovine
2.2. Newborn Calf and Adult Bovine Sera
2.3. Others

3. Reagents Type
3.1. Albumin
3.1.1. Bovine Serum Albumin (BSA)
3.1.2. Human Serum Albumin (HSA)
3.1.3. Recombinant Serum Albumin (RSA)
3.2. Amino Acids
3.3. Attachment Factors
3.4. Growth Factors & Cytokines
3.4.1. HumanKine Growth Factors and Cytokine
3.4.2. Insulin-like Growth Factors (IGF)
3.4.3. Tumor Necrosis Factor (TNF)
3.4.4. Others
3.5. Hormones (Insulin, Recombinant Insulin, Erythropoietin and Others)
3.6. Others
3.6.1. Porcine Trypsin
3.6.2. Recombinant Trypsin
3.6.3. Thrombin
3.6.4. Miscellaneous Reagents

4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World

5. Company Profiles
5.1. Becton, Dickinson and Company
5.2. Corning Life Sciences B.V.
5.3. EMD Millipore
5.4. GE Healthcare
5.5. Lonza Group Ltd.
5.6. PromoCell GmbH
5.7. Sigma-Aldrich Co. LLC
5.8. Thermo Fisher Scientific, Inc.
5.9. VWR International, LLC
5.10. Wheaton Industries, Inc.

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.